Daktari Diagnostics
Cambridge, US · Delaware corporation · 2 known investors
Biotech
Founders & leadership
DH
Donald HawthorneExecutive
CE
Christopher EarlNamed on SEC filing
SL
Stanley LapidusNamed on SEC filing
RK
Roger KittermanNamed on SEC filing
WR
William RodriguezNamed on SEC filing
ER
Edward RobertsNamed on SEC filing
Board
AS
PK
Peter KasparBoard director
TB
Thierry BernardBoard director
DR
David RubinBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$42.5M disclosed across 2 rounds · 2013–2015
▶$22.5MraisedMay 2016 · 31 investors · BiotechnologyRule 506(b)
▶$22.5MraisedMay 2016 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter KasparDirector
- Aaron SandoskiDirector
- Thierry BernardDirector
- David RubinDirector
- Donald HawthorneExecutive Officer, Director
- Offering amount
- $22.5M
- Amount sold
- $22.5M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedApr 2014 · 27 investors · BiotechnologyRule 506(b)
▶$20MraisedApr 2014 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aaron SandoskiDirector
- Christopher EarlDirector
- Stanley LapidusDirector
- Roger KittermanDirector
- William RodriguezExecutive Officer, Director
- David RubinDirector
- Edward RobertsDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Apr 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $221.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $649.6K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase I | 2016 | $148K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $448.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $153.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Daktari Diagnostics's investors?
- Daktari Diagnostics's investors include Boston Harbor Angels, Norwich Ventures.
- How much funding has Daktari Diagnostics raised?
- Daktari Diagnostics has disclosed $42.5M raised across 2 rounds.
- Where is Daktari Diagnostics headquartered?
- Daktari Diagnostics is headquartered in Cambridge, US.